Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1190

    3.

    Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.

    Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain RL, Swindle RW.

    J Manag Care Pharm. 2006 Jan-Feb;12(1):43-54.PMID: 16420107 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effect of improved glycemic control on health care costs and utilization.

    Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC.

    JAMA. 2001 Jan 10;285(2):182-9.PMID: 11176811 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Disease management for diabetes mellitus: impact on hemoglobin A1c.

    Sidorov J, Gabbay R, Harris R, Shull RD, Girolami S, Tomcavage J, Starkey R, Hughes R.

    Am J Manag Care. 2000 Nov;6(11):1217-26.PMID: 11185847 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Quality of outpatient care provided to diabetic patients. A health maintenance organization experience.

    Peters AL, Legorreta AP, Ossorio RC, Davidson MB.

    Diabetes Care. 1996 Jun;19(6):601-6.PMID: 8725859 [PubMed - indexed for MEDLINE]Related articles

    7.

    Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization.

    Gary TL, McGuire M, McCauley J, Brancati FL.

    Dis Manag. 2004 Spring;7(1):25-34.PMID: 15035831 [PubMed - indexed for MEDLINE]Related articles

    8.

    Diabetes disease management in managed care organizations.

    Lynne D.

    Dis Manag. 2004 Spring;7(1):47-60.PMID: 15035833 [PubMed - indexed for MEDLINE]Related articles

    9.

    A cost effectiveness study of integrated care in health services delivery: a diabetes program in Australia.

    McRae IS, Butler JR, Sibthorpe BM, Ruscoe W, Snow J, Rubiano D, Gardner KL.

    BMC Health Serv Res. 2008 Oct 6;8:205.PMID: 18834551 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Diabetes disease management in a community-based setting.

    Berg GD, Wadhwa S.

    Manag Care. 2002 Jun;11(6):42, 45-50.PMID: 12098874 [PubMed - indexed for MEDLINE]Related articles

    11.

    Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

    Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL.

    J Manag Care Pharm. 2006 Sep;12(7):546-54.PMID: 16981800 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Outpatient management of diabetes mellitus in five Arizona Medicare managed care plans.

    Marshall CL, Bluestein M, Chapin C, Davis T, Gersten J, Harris C, Hodgin A, Larsen W, Rigberg H, Krishnaswami V, Darling B.

    Am J Med Qual. 1996 Summer;11(2):87-93.PMID: 8704502 [PubMed - indexed for MEDLINE]Related articles

    13.

    Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.

    Laliberté F, Bookhart BK, Vekeman F, Corral M, Duh MS, Bailey RA, Piech CT, Lefebvre P.

    J Manag Care Pharm. 2009 May;15(4):312-22.PMID: 19422271 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

    Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

    J Manag Care Pharm. 2008 Mar;14(2):176-85.PMID: 18331119 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services?

    Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA.

    Diabetes Care. 2003 Mar;26(3):738-43.PMID: 12610031 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.

    Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J.

    J Manag Care Pharm. 2006 Mar;12(2):121-9.PMID: 16515370 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes.

    Nguyen HQ, Ackermann RT, Berke EM, Cheadle A, Williams B, Lin E, Maciejewski ML, LoGerfo JP.

    Diabetes Care. 2007 Jan;30(1):43-8.PMID: 17192331 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Improvements in diabetes management and outcomes in a Medicaid managed care system.

    Bailey JE, Womeodu RJ, Wan JY, Van Brunt DL, Somes GW.

    Tenn Med. 2001 Nov;94(11):425-30.PMID: 11709896 [PubMed - indexed for MEDLINE]Related articles

    19.

    Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes.

    Shetty S, Secnik K, Oglesby AK.

    J Manag Care Pharm. 2005 Sep;11(7):559-64.PMID: 16137213 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Quality improvement and cost reduction realized by a purchaser through diabetes disease management.

    Snyder JW, Malaskovitz J, Griego J, Persson J, Flatt K.

    Dis Manag. 2003 Winter;6(4):233-41.PMID: 14736347 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data